NEKTAR THERAPEUTICS's ticker is and the CUSIP is 640268908. A total of 5 filers reported holding NEKTAR THERAPEUTICS in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $68,000 | -56.1% | 12,700 | +10.4% | 0.00% | – |
| Q4 2021 | $155,000 | -84.4% | 11,500 | -76.8% | 0.00% | – |
| Q1 2021 | $992,000 | -56.1% | 49,600 | -52.6% | 0.00% | – |
| Q4 2019 | $2,258,000 | +12.7% | 104,600 | -4.9% | 0.00% | – |
| Q3 2019 | $2,004,000 | -3.7% | 110,000 | +83.3% | 0.00% | – |
| Q2 2019 | $2,081,000 | -31.2% | 60,000 | -33.3% | 0.00% | -100.0% |
| Q1 2019 | $3,024,000 | +67.3% | 90,000 | +63.6% | 0.00% | – |
| Q4 2018 | $1,808,000 | +97.8% | 55,000 | +266.7% | 0.00% | – |
| Q3 2018 | $914,000 | -37.6% | 15,000 | -50.0% | 0.00% | – |
| Q2 2018 | $1,465,000 | -9.1% | 30,000 | +11.1% | 0.00% | – |
| Q4 2017 | $1,612,000 | -20.9% | 27,000 | -74.1% | 0.00% | – |
| Q2 2017 | $2,037,000 | -16.7% | 104,200 | 0.0% | 0.00% | -100.0% |
| Q1 2017 | $2,446,000 | – | 104,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PURA VIDA INVESTMENTS, LLC | 36,600 | $139,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 178,700 | $679,000 | 0.00% |
| SIMPLEX TRADING, LLC | 245,500 | $932,000 | 0.00% |
| JANE STREET GROUP, LLC | 160,000 | $608,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |